88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients PALMA DE MALLORCA, Spain , July 24, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406 SHANGHAI , July 24, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that all cohorts of healthy volunteers have been dosed in an Australian Phase I ... 2026-07-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 24, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery ... 2026-07-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fapon Showcases AI-Engineered Enzymes and Alzheimer's Solutions at ADLM 2026, Reinforcing North American Commitment ANAHEIM, Calif. , July 24, 2026 /PRNewswire/ -- Fapon, a trusted global IVD provider with deepening roots in North America, will exhibit at ADLM 2026 from July 26 to 30 in Anaheim, California. The company ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
AH-008 Achieves Key Clinical Milestone with Successful First Subject First Dose (FSFD) in Phase I Study for Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN) TAIPEI , July 23, 2026 /PRNewswire/ -- AnHorn Medicines today announced the successful completion of the first subject first dose in the Phase I clinical trial of AH-008, a first-in-class neuroprotective ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Zhongchao Inc. Announces $5.0 Million Registered Direct Offering SHANGHAI , July 23, 2026 /PRNewswire/ -- Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain ... 2026-07-23T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH BEIJING , July 23, 2026 /PRNewswire/ -- Haisco Pharmaceutical Group claimed today their independently developed Class 1 innovative drug, Ciprocopan Succinate Tablets (development code: HSK39297), ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases Partnership grants Ignaz Semmelweis Institute access to Nona's H2L2 Harbour Mice ® transgenic mouse technology platform for translational antibody research ... 2026-07-23T Biotechnology Higher Education Medical/Pharmaceuticals
Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting - Fixed-dose combination of ASC36 and ASC35 (ASC36_35 FDC) demonstrated superior weight loss compared to eloralintide in combination with tirzepatide in a diet-induced obese (DIO) animal model. ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Samsung Biologics Reports Second Quarter 2026 Financial Results Recorded Q2'26 revenue of KRW 1,321 billion and operating profit of KRW 586 billion Delivered stable business performance through continued disciplined execution Expanded global presence while advancing ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved